AU2002334027B2 - Novel method for synthesis of (2S, 3AS, 7AS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid derivatives and use for synthesis of perindopril - Google Patents
Novel method for synthesis of (2S, 3AS, 7AS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid derivatives and use for synthesis of perindopril Download PDFInfo
- Publication number
- AU2002334027B2 AU2002334027B2 AU2002334027A AU2002334027A AU2002334027B2 AU 2002334027 B2 AU2002334027 B2 AU 2002334027B2 AU 2002334027 A AU2002334027 A AU 2002334027A AU 2002334027 A AU2002334027 A AU 2002334027A AU 2002334027 B2 AU2002334027 B2 AU 2002334027B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- compound
- synthesis
- perindopril
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Description
NEW PROCESS FOR THE SYNTHESIS OF (2S, 3aS, 7aS)-I-[(S)-ALANYL]- OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID COMPOUNDS AND APPLICATION IN THE SYNTHESIS OF PERINDOPRIL The present invention relates to a process for the industrial synthesis of compounds of formula 'CO2R,
NHR
2 wherein R 1 represents a hydrogen atom, a linear or branched (Ci-C 6 )alkyl group or a benzyl group, and R2 represents a group that protects the amino function, and to their application in the industrial synthesis of perindopril of formula (II)
H
SN COH I) and of its pharmaceutically acceptable salts.
Perindopril, and also pharmaceutically acceptable salts thereof, and more especially the tert-butylamine salt thereof, have valuable pharmacological properties.
Their principal property lies in the inhibition of the enzyme that converts angiotensin I (or kininase II), which enables on the one hand prevention of the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II (vasoconstrictor), and on the other hand prevention of the degradation of bradykinin (vasodilator) to inactive peptide.
Those two actions contribute to the beneficial effects of perindopril in cardiovascular disorders, especially arterial hypertension and cardiac insufficiency.
Perindopril, its preparation and its therapeutic use have been described in European Patent EP 0 049 658.
Given the pharmaceutical value of that compound, it is important to be able to obtain it by an effective industrial synthesising process that can readily be applied on an industrial scale, yielding perindopril in a good yield and, especially, with an excellent degree of purity.
Patent Specification EP 0 308 341 describes the industrial synthesis of perindopril by catalytic hydrogenation of (2S)-2,3-dihydroindole-2-carboxylic acid, followed by coupling of the resulting (2S, 3aS, 7aS)-octahydroindole-2-carboxylic acid benzyl ester with l-carboxybutyl]-(S)-alanine ethyl ester, and then deprotection of the carboxylic group of the heterocycle by catalytic hydrogenation.
That process has the advantage of yielding perindopril in a good yield. However, the purity of the perindopril obtained by that process is not satisfactory, and necessitates a purification step in order to obtain perindopril of a quality that would allow its use as a pharmaceutical active ingredient.
Indeed, under the conditions described in that patent specification the perindopril obtained is contaminated by significant amounts of the impurities of formulae (III) and (IV)
H
OH
N
HC- 0 0 N "O
CH
/NZ
H
OH
H 1 HCA 0
N
o 0 (IIl) The Applicant has now developed a new industrial synthesising process that, without requiring laborious purification, yields perindopril of a purity that is compatible with its use as a pharmaceutical active ingredient, and that is, for example, totally free of the impurities of formulae (III) and (IV).
Moreover, the process uses alanine as its source of chirality, alanine being a natural and, accordingly, inexpensive starting material.
More specifically, the present invention relates to a process for the industrial synthesis of the compound of formula 'CO2R, wherein Ri represents a hydrogen atom, a linear or branched (Ci-C 6 )alkyl group or a benzyl group, and R 2 represents a group that protects the amino function, characterised in that the ester of formula N CO2R,
H
wherein Ri is as defined for formula is reacted with the alanine compound of formula (VI)
CH
A (VI) R2HN CO2H wherein R 2 is as defined for formula in an organic solvent, such as, for example, tetrahydrofuran or ethyl acetate, in the absence of 1-hydroxybenzotriazole or in the presence of an amount of less than 0.6 mol of 1-hydroxybenzotriazole per mol of compound of formula employed, in the presence of an amount of from 1 to 1.2 mol of dicyclohexylcarbodiimide per mol of compound of formula employed, and in the presence of an amount of from 1 to 1.2 mol of triethylamine per mol of compound of formula employed, at a temperature of from 20 to 50 0
C,
to yield, after isolation and then recrystallisation, the compound of formula (VII) N
CO
2
R
=0 (VII) wherein Ri and R 2 are as defined hereinbefore, which is hydrogenated in the presence of a catalyst, such as, for example, Pd/C, Rh/C, Pt/C, Ni/C or PtO 2 under a hydrogen pressure of from I to 40 bars, at a temperature of from 30 to 70 0 C, to yield the compound of formula The compound of formula so obtained is then subjected, where appropriate, to a reaction for the deprotection of the acid and amine functions, followed by a coupling reaction, either with ethyl 2-oxo-pentanoate under conditions of reductive amination, or with a compound of formula (XII)
CH
3 X '(RCO2Et wherein X represents a leaving group selected from a halogen atom, -O-SO2CH 3 and -O-SO2 CH to yield optically pure perindopril, which is converted, if desired, into a pharmaceutically acceptable salt such as the tert-butylamine salt.
The process is of particular interest for the following reasons The coupling in alkaline medium of the (2S, 3aS, 7aS)-octahydroindole-2-carboxylic acid benzyl ester of formula (VIII)
H
S
(VIII)
N CO 2 Bn H H with the compound of formula (IX) has been described in Patent Specification EP 0 308 341.
CH
3 S CH 3
(IX)
EtO2C NH(s)'CO2H However, the perindopril benzyl ester so obtained is contaminated by a number of byproducts.
In particular, it contains significant amounts (5 to 15 of the impurities of formulae and (XI) resulting from the reaction of the coupling product with dicyclohexylcarbodiimide, which impurities, after debenzylation, yield the impurities of formulae (III) and (IV).
H
H
OBn OBn
H
3 C 0 HoC N CH,
VZCH,
(X0 The Applicant has found that the coupling reaction of the compound of formula (V) with the compound of formula (VI) yields a compound of formula (VII) that is totally free of the impurities resulting from the reaction of the coupling product with dicyclohexylcarbodiimide.
The compound of formula (VII) so obtained yields perindopril of far better purity, and that is in particular totally free of the impurities of formulae (III) and (IV).
Moreover, the Applicant has found that it was possible to obtain the intermediate compound of formula (VII) in a crystalline form that was readily purifiable.
Its conversion according to the process of the invention thus yields the compound of formula in excellent purity.
The Examples below illustrate the invention, but do not limit it in any way.
Example I: Methyl (2S)-l-{(2S)-2-[(tert-butyloxycarbonyl)-aminoJ-propionyl}-2,3dihydro-IH-indole-2-carboxylate There are introduced into a reactor, with stirring, 2.13 kg of methyl (2S)-2,3-dihydroindole- 2-carboxylate, 1 kg of triethylamine, 30 litres of tetrahydrofuran and then, after 10 minutes' stirring at room temperature, 1.9 kg of N-[tert-butyloxycarbonyl]-(S)-alanine and 2 kg of dicyclohexylcarbodiimide. The heterogeneous mixture is then stirred at room temperature for 6 hours, and is subsequently cooled to 0°C and filtered.
The filtrate is then washed and recrystallised from a mixture of hexane/ethyl acetate 10/1 to yield the expected product in a yield of 81% and with a chemical purity of 98%.
Meltingoint 130-131°C Elemental microanalysis C% H% N% calculated 62.05 6.94 8. 04 found 61.80 6.94 8.00 Example 2: Methyl (2S, 3aS, 7aS)-i-{(2S)-2-[(tert-butyloxycarbonyl)-amino]propionylf-octahydro-1H-indole-2-carboxylate method 1 The residue obtained in Example 1 (1 kg) is dissolved in methanol and transferred to a hydrogenator, and then 0.10 kg of 5% rhodium-on-carbon is added.
The mixture is then hydrogenated under a pressure of 30 bars, at a temperature of 60 0
C,
until absorption of the theoretical amount of hydrogen.
After removal of the catalyst by filtration, the solvent is removed by evaporation to yield the expected product in a yield of 90% and with a chemical purity of 98%.
Example 3 Methyl (2S, 3aS, 7aS)-l-{(2S)-2-f(tert-butyloxycarbonyl)-aminopropionyl-octahydro-lH-indole-2-carboxylate method 2 The residue obtained in Example 1 (1 kg) is dissolved in acetic acid and transferred to a hydrogenator, and then 0.10 kg of platinum dioxide is added.
The mixture is then hydrogenated under a pressure of 10 bars at a temperature of 40 0
C,
until absorption of the theoretical amount of hydrogen.
After removal of the catalyst by filtration, the solvent is removed by evaporation to yield the expected product in a yield of 90% and with a chemical purity of 98%.
Claims (7)
1. Process for the industrial synthesis of the compound of formula (I) H (S) -N C0 2 R, (I) C H H CH 3 (s) O NHR 2 wherein Ri represents a hydrogen atom, a linear or branched (Ci-C 6 )alkyl group or a benzyl group, and R 2 represents a group that protects the amino function, characterised in that the ester of formula wherein Ri is as defined for formula is reacted with the alanine compound of formula (VI): CH3 R2HN- CO2H (VI) wherein R2 is as defined for formula in an organic solvent, such as, for example, tetrahydrofuran or ethyl acetate, in the absence of 1-hydroxybenzotriazole or in the presence of an amount of less than 0.6 mol of 1-hydroxybenzotriazole per mol of compound of formula employed, in the presence of an amount of from I to 1.2 mol of dicyclohexylcarbodiimide per mol of compound of formula employed, and in the presence of an amount of from I to 1.2 mol of triethylamine per mol of compound of formula employed, at a temperature of from 20 to 50 0 C, to yield, after isolation and then recrystallisation, the compound of formula (VII) N CO 2 RI HC- O (VII) NHR 2 wherein RI and R2 are as defined hereinbefore, which is hydrogenated in the presence of a catalyst, such as, for example, Pd/C, Rh/C, Pt/C, Ni/C or PtO 2 under a hydrogen pressure of from 1 to 40 bars, at a temperature of from 30 to 70 0 C, to yield the compound of formula
2. Process for the synthesis of the compound of formula according to claim 1, characterised in that the catalyst employed in the hydrogenation step is rhodium-on- carbon.
3. Process for the synthesis of the compound of formula according to claim 1, characterised in that the catalyst employed in the hydrogenation step is platinum dioxide.
4. Process for the synthesis of the compound of formula according to any one of claims 1 to 3, characterised in that R, represents a methyl group.
Process for the synthesis of perindopril or pharmaceutically acceptable salts thereof starting from a compound of formula characterised in that the compound of formula is obtained by the synthesis process according to any one of claims 1 to 4.
6. Synthesis process according to claim 5, characterised in that the perindopril obtained is free of the impurities of formulae (III) and (IV). H OH H 3 C O O ,CH H OH H CH OZ N CH 3 0 N <J 0 (IV)
7. The process substantially as hereinbefore described with reference to the accompanying examples. DATED this 28th day of November 2006 Les Laboratoires Servier WATERMARK PATENT TRADE MARK ATTORNEYS 290 BURWOOD ROAD HAWTHORN VICTORIA 3122 AUSTRALIA P23607AU00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR01/09839 | 2001-07-24 | ||
| FR0109839A FR2827860B1 (en) | 2001-07-24 | 2001-07-24 | NOVEL PROCESS FOR SYNTHESIS OF ACID DERIVATIVES (2S, 3AS, 7AS) -1 - [(S) -ALANYL] -OCTAHYDRO-1H-INDOLE-2-CARBOXYLINE AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL |
| PCT/FR2002/002627 WO2003016336A1 (en) | 2001-07-24 | 2002-07-23 | Novel method for synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid derivatives and use for synthesis of perindopril |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2002334027A1 AU2002334027A1 (en) | 2003-03-03 |
| AU2002334027B2 true AU2002334027B2 (en) | 2006-12-14 |
| AU2002334027B8 AU2002334027B8 (en) | 2007-01-25 |
Family
ID=8865826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002334027A Ceased AU2002334027B8 (en) | 2001-07-24 | 2002-07-23 | Novel method for synthesis of (2S, 3AS, 7AS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid derivatives and use for synthesis of perindopril |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7060842B2 (en) |
| EP (1) | EP1256590B1 (en) |
| JP (1) | JP3868957B2 (en) |
| KR (1) | KR100607556B1 (en) |
| CN (1) | CN1533398A (en) |
| AR (1) | AR035081A1 (en) |
| AT (1) | ATE318838T1 (en) |
| AU (1) | AU2002334027B8 (en) |
| BR (1) | BR0211334A (en) |
| CA (1) | CA2455706C (en) |
| DE (1) | DE60209458T2 (en) |
| DK (1) | DK1256590T3 (en) |
| EA (1) | EA005490B1 (en) |
| ES (1) | ES2259071T3 (en) |
| FR (1) | FR2827860B1 (en) |
| HU (1) | HU229396B1 (en) |
| MA (1) | MA27130A1 (en) |
| MX (1) | MXPA04000443A (en) |
| NO (1) | NO328234B1 (en) |
| NZ (1) | NZ530427A (en) |
| PL (1) | PL212408B1 (en) |
| PT (1) | PT1256590E (en) |
| SI (1) | SI1256590T1 (en) |
| WO (1) | WO2003016336A1 (en) |
| ZA (1) | ZA200400246B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2289060T3 (en) * | 2002-01-30 | 2008-02-01 | Les Laboratoires Servier | PROCESS FOR THE PREPARATION OF HIGH PURITY PERINDOPRILE AND USEFUL INTERMEDIATES IN ITS SYNTHESIS. |
| ES2250846T3 (en) * | 2003-02-28 | 2006-04-16 | Les Laboratoires Servier | NEW PROCEDURE FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS. |
| DE60301980T2 (en) * | 2003-02-28 | 2006-07-27 | Les Laboratoires Servier | Process for the synthesis of the (2S, 3aS, 7aS) -perhydroindole-2-carboxylic acid and its esters, used in the synthesis of perindopril |
| DK1403277T3 (en) * | 2003-02-28 | 2005-11-21 | Servier Lab | Process for Synthesis of (2S, 3aS, 7aS) -1 - ((S) -alanyl) -octahydro-1H-indole-2-carboxylic acid derivatives and their use in synthesis in perindopril |
| ES2307923T3 (en) | 2003-02-28 | 2008-12-01 | Les Laboratoires Servier S.A. | PROCEDURE FOR PREPARATION OF PERINDOPRIL AND SALTS OF THE SAME. |
| ES2231760T3 (en) * | 2003-03-12 | 2005-05-16 | Les Laboratoires Servier | NEW ACID SYNTHESIS PROCEDURE (2S, 3AS, 7AS) PERHYDROINDOL-2-CARBOXYL AND ITS ESTERS, AND ITS APPLICATION TO PERINDOPRIL SYNTHESIS. |
| SI1323729T1 (en) * | 2003-03-12 | 2005-02-28 | Les Laboratoires Servier | Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof derivatives; and use in the synthesis of perindopril |
| PT1321471E (en) * | 2003-03-12 | 2005-07-29 | Servier Lab | NEW SYNTHESIS OF PERINDOPRIL AND ITS ACEITABLE SALTS UNDER THE PHARMACEUTICAL VISION |
| CA2530550C (en) | 2003-06-24 | 2017-04-04 | Christoph Straessler | New crystalline forms of perindopril erbumine |
| ES2271498T3 (en) * | 2003-07-31 | 2007-04-16 | Les Laboratoires Servier | NEW SYNTHESIS PROCEDURE OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS. |
| JP4720132B2 (en) * | 2003-10-30 | 2011-07-13 | 住友化学株式会社 | Process for producing optically active N-protected-octahydro-1H-indole-2-carboxylic acid |
| EP1420030A3 (en) * | 2003-12-10 | 2004-05-26 | Les Laboratoires Servier | Method for synthesis of (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indole-2- carboxylic acid derivatives and use in the synthesis of perindopril |
| GB2413128A (en) * | 2004-04-13 | 2005-10-19 | Neopharma Ltd | Process for the preparation of perindopril |
| ITFI20040174A1 (en) * | 2004-08-03 | 2004-11-03 | Protera S R L | ARYTHOLPHONAMIDIC DERIVATIVES OF HYDROXAMIC ACID WITH INHIBITORY ACTION OF METALLOPROTEINASE |
| KR101329457B1 (en) | 2006-12-19 | 2013-11-15 | 에스케이바이오팜 주식회사 | Method for preparing Octahydroindole-2-carboxylic acid |
| PH12018502155B1 (en) | 2016-04-20 | 2024-03-27 | Servier Lab | Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2503155A2 (en) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | NOVEL SUBSTITUTED IMINO DIACIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS AN ENZYME INHIBITOR |
| FR2620709B1 (en) * | 1987-09-17 | 1990-09-07 | Adir | PROCESS FOR THE INDUSTRIAL SYNTHESIS OF PERINDOPRIL AND ITS MAIN INTERMEDIATE SYNTHESIS |
| FR2807037B1 (en) * | 2000-03-31 | 2002-05-10 | Adir | NOVEL PROCESS FOR SYNTHESIS OF N - [(s) -1- CARBOXYBUTYL] - (S) -ALANINE ESTERS AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL |
| FR2807431B1 (en) * | 2000-04-06 | 2002-07-19 | Adir | NOVEL PROCESS FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
| FR2807430B1 (en) * | 2000-04-11 | 2002-05-17 | Adir | NOVEL PROCESS FOR THE SYNTHESIS OF N - [(S) -1- CARBOXYBUTYL] - (S) -ALANINE ESTERS AND APPLICATION TO THE SYNTHESIS OF PERINDOPRIL |
-
2001
- 2001-07-24 FR FR0109839A patent/FR2827860B1/en not_active Expired - Fee Related
-
2002
- 2002-07-23 ES ES02291853T patent/ES2259071T3/en not_active Expired - Lifetime
- 2002-07-23 DE DE60209458T patent/DE60209458T2/en not_active Expired - Lifetime
- 2002-07-23 JP JP2003521258A patent/JP3868957B2/en not_active Expired - Fee Related
- 2002-07-23 CA CA2455706A patent/CA2455706C/en not_active Expired - Fee Related
- 2002-07-23 AU AU2002334027A patent/AU2002334027B8/en not_active Ceased
- 2002-07-23 US US10/484,022 patent/US7060842B2/en not_active Expired - Lifetime
- 2002-07-23 MX MXPA04000443A patent/MXPA04000443A/en active IP Right Grant
- 2002-07-23 AR ARP020102757A patent/AR035081A1/en not_active Application Discontinuation
- 2002-07-23 SI SI200230292T patent/SI1256590T1/en unknown
- 2002-07-23 DK DK02291853T patent/DK1256590T3/en active
- 2002-07-23 AT AT02291853T patent/ATE318838T1/en active
- 2002-07-23 KR KR1020047001052A patent/KR100607556B1/en not_active Expired - Fee Related
- 2002-07-23 BR BR0211334-1A patent/BR0211334A/en not_active IP Right Cessation
- 2002-07-23 EA EA200400110A patent/EA005490B1/en not_active IP Right Cessation
- 2002-07-23 NZ NZ530427A patent/NZ530427A/en not_active IP Right Cessation
- 2002-07-23 PT PT02291853T patent/PT1256590E/en unknown
- 2002-07-23 EP EP02291853A patent/EP1256590B1/en not_active Expired - Lifetime
- 2002-07-23 WO PCT/FR2002/002627 patent/WO2003016336A1/en active IP Right Grant
- 2002-07-23 CN CNA028146093A patent/CN1533398A/en active Pending
- 2002-07-24 PL PL355159A patent/PL212408B1/en unknown
- 2002-07-24 HU HU0202437A patent/HU229396B1/en not_active IP Right Cessation
-
2004
- 2004-01-08 MA MA27474A patent/MA27130A1/en unknown
- 2004-01-13 NO NO20040151A patent/NO328234B1/en not_active IP Right Cessation
- 2004-01-13 ZA ZA200400246A patent/ZA200400246B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002334027B2 (en) | Novel method for synthesis of (2S, 3AS, 7AS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid derivatives and use for synthesis of perindopril | |
| AU2001248470B2 (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| AU2004255899A1 (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| AU2004270429B2 (en) | Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof | |
| JP4331205B2 (en) | Novel synthesis method of perindopril and pharmaceutically acceptable salts thereof | |
| CN1331883C (en) | Method for synthesis of (2s,3as,7as)-1-((s)-alanyl)-octahydro-1h-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril | |
| JP4331206B2 (en) | Novel synthesis method of perindopril and pharmaceutically acceptable salts thereof | |
| US20070123581A1 (en) | Process for the synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid compounds and application in the synthesis of perindopril |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TH | Corrigenda |
Free format text: IN VOL 20, NO 48, PAGE(S) 4886 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME LES LABORATOIRES SERVIER, APPLICATION NO. 2002334027, UNDER INID (72) CORRECT THE CO-INVENTOR NAME PORCS-MAKKAY, MARTA |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| GD | Licence registered |
Name of requester: SERVIER LABORATORIES |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |